These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20837898)

  • 1. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.
    Piano MR; Benowitz NL; Fitzgerald GA; Corbridge S; Heath J; Hahn E; Pechacek TF; Howard G;
    Circulation; 2010 Oct; 122(15):1520-44. PubMed ID: 20837898
    [No Abstract]   [Full Text] [Related]  

  • 2. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statement on smoking and cardiovascular disease for health care professionals. American Heart Association.
    Jonas MA; Oates JA; Ockene JK; Hennekens CH
    Circulation; 1992 Nov; 86(5):1664-9. PubMed ID: 1423984
    [No Abstract]   [Full Text] [Related]  

  • 5. Should doctors advocate snus and other nicotine replacements? No.
    Macara AW
    BMJ; 2008 Feb; 336(7640):359. PubMed ID: 18276711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor in response to "An epidemic that deserves more attention: epidemiology, prevention, and treatment of smokeless tobacco".
    Phillips CV; Heavner KK
    South Med J; 2008 Feb; 101(2):211; author reply 211-2. PubMed ID: 18364630
    [No Abstract]   [Full Text] [Related]  

  • 7. Tobacco smoking, harm reduction, and nicotine product regulation.
    Britton J; Edwards R
    Lancet; 2008 Feb; 371(9610):441-5. PubMed ID: 17920116
    [No Abstract]   [Full Text] [Related]  

  • 8. Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami DK; Lemmonds C; Tomar SL
    Prev Med; 2004 Mar; 38(3):309-17. PubMed ID: 14766113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yet another smoke(less) screen?
    Goldman L
    Am J Med; 1998 May; 104(5):498. PubMed ID: 9626036
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating cigarette smoking with smokeless tobacco: a flawed recommendation.
    Jorenby DE; Fiore MC; Smith SS; Baker TB
    Am J Med; 1998 May; 104(5):499-500. PubMed ID: 9626037
    [No Abstract]   [Full Text] [Related]  

  • 11. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.
    Zeller M; Hatsukami D;
    Tob Control; 2009 Aug; 18(4):324-32. PubMed ID: 19240228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and cardiovascular effects of smokeless tobacco.
    Arabi Z
    J Cardiometab Syndr; 2006; 1(5):345-50. PubMed ID: 17679792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control.
    NIH State-of-the-Science Panel
    Ann Intern Med; 2006 Dec; 145(11):839-44. PubMed ID: 16954353
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine addiction among American youth.
    Grabiak BR
    ORL Head Neck Nurs; 1996; 14(2):13-5. PubMed ID: 8788361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)].
    Trofor A; Eşanu V; Frasilă EL
    Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokeless tobacco as a smoking cessation strategy.
    Rodu B
    Adv Nurse Pract; 2003 Jul; 11(7):18; author reply 18. PubMed ID: 12886730
    [No Abstract]   [Full Text] [Related]  

  • 19. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of cancer and other systemic effects associated with the use of smokeless tobacco.
    Winn DM
    Adv Dent Res; 1997 Sep; 11(3):313-21. PubMed ID: 9524431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.